Biotech & Medicine
53 articles RSS
Microbiome Research Converges on Hidden Gut Bacteria, Infant Allergy Prevention, and Cancer Immunotherapy
A Cambridge-led study identifies CAG-170 bacteria as a global marker of gut health, Siolta Therapeutics reports a 64 percent reduction in infant atopic dermatitis risk, and UF Health isolates a bacterial metabolite that doubles lung cancer immunotherapy response in mice.
First Epigenetic Reprogramming Therapy Enters Human Trials as Longevity Science Reaches a Clinical Turning Point
Life Biosciences began the first human trial of a cellular rejuvenation therapy using partial epigenetic reprogramming in Q1 2026, while senolytic pilot data shows safety in Alzheimer's-risk patients.
Basecamp Research Launches Trillion Gene Atlas to Map 100 Million Species and Accelerate AI-Designed Therapeutics
Basecamp Research launches the Trillion Gene Atlas, a two-year initiative to expand known genetic diversity 100-fold by sequencing over 100 million species with partners Anthropic, Ultima Genomics, PacBio, and NVIDIA.
Insulet Recalls Omnipod 5 Insulin Pods After 18 Serious Adverse Events Linked to Internal Tubing Defect
Insulet has initiated a voluntary recall of certain Omnipod 5 insulin pump pods after a manufacturing defect caused insulin to leak inside the device rather than reaching patients, leading to 18 serious adverse events including hospitalizations for diabetic ketoacidosis.
Brain-Computer Interfaces Enter the Commercial Era as China Grants First Approval and BrainGate Achieves Near-Able-Bodied Typing Speeds
China's NMPA approves the world's first commercial brain implant while a BrainGate study demonstrates 110-character-per-minute typing, marking a pivotal week for neural interface technology.
Federal Judge Blocks Kennedy's Overhaul of U.S. Childhood Vaccine Schedule, Invalidates Reconstituted Advisory Panel
A federal court has halted sweeping changes to the national childhood immunization schedule and frozen Kennedy's ACIP appointments, finding the reconstituted panel likely violated federal law.
Mass General Team's INSTALL Platform Solves Gene Therapy's Immune Toxicity Problem, Enabling Safe Non-Viral DNA Insertion in Living Mice
A Nature paper describes INSTALL, a gene editing platform using circular single-stranded DNA to insert therapeutic genes without triggering fatal immune responses, keeping mice healthy at doses where conventional DNA proved lethal.
FDA Lifts Clinical Hold on Intellia's CRISPR Gene-Editing Trial for Heart Disease After Patient Death and Safety Overhaul
The FDA has cleared Intellia Therapeutics to resume its MAGNITUDE Phase 3 trial of nexiguran ziclumeran for ATTR cardiomyopathy, five months after a patient death and subsequent clinical hold prompted a safety overhaul.
Sana Biotechnology Reports 14-Month Survival of Transplanted Islet Cells Without Immunosuppression in a Type 1 Diabetes Patient
Gene-edited pancreatic islet cells transplanted into a patient with type 1 diabetes continue producing insulin 14 months later with no immunosuppressive drugs, advancing the case for a functional cure.
FDA Issues Warning Letter to Novo Nordisk Over Unreported Semaglutide Deaths and Systematic Pharmacovigilance Failures
The FDA cited Novo Nordisk for serious violations of adverse event reporting requirements after a 2025 inspection found the company failed to report three patient deaths linked to semaglutide, including one suicide, and lacked adequate procedures for post-marketing drug safety surveillance.
FDA Pushes Back Orforglipron Decision to April as National Priority Voucher Program Hits Early Turbulence
The FDA has delayed its decision on Eli Lilly's oral obesity pill orforglipron from March 28 to April 10, alongside delays for three other drugs in the new expedited review program.
In Vivo CAR-T Therapy Delivers First Human Proof-of-Concept for Autoimmune Reset, Bypassing Lab Manufacturing
MagicRNA's mRNA lipid nanoparticle therapy reprogrammed patients' own T cells inside the body, wiping out disease-driving B cells in refractory lupus patients without conventional cell manufacturing.